These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 7483725)
21. Debrisoquine hydroxylation and sulfamethazine acetylation in a Chinese population. Xu XM; Jiang WD Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):385-8. PubMed ID: 2130590 [TBL] [Abstract][Full Text] [Related]
22. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. Aklillu E; Persson I; Bertilsson L; Johansson I; Rodrigues F; Ingelman-Sundberg M J Pharmacol Exp Ther; 1996 Jul; 278(1):441-6. PubMed ID: 8764380 [TBL] [Abstract][Full Text] [Related]
23. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients. Roots I; Brockmöller J; Drakoulis N; Loddenkemper R Clin Investig; 1992; 70(3-4):307-19. PubMed ID: 1355678 [TBL] [Abstract][Full Text] [Related]
24. Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans. Abolfathi Z; Fiset C; Gilbert M; Moerike K; Bélanger PM; Turgeon J J Pharmacol Exp Ther; 1993 Sep; 266(3):1196-201. PubMed ID: 8371133 [TBL] [Abstract][Full Text] [Related]
25. N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances. Gawrońska-Szklarz B; Górnik W; Pawlik A; Kunicki P; Wójcicki J; Sitkiewicz D; Sych Z Eur J Clin Pharmacol; 1997; 51(6):431-5. PubMed ID: 9112055 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population. Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134 [TBL] [Abstract][Full Text] [Related]
31. 1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans. Eiermann B; Edlund PO; Tjernberg A; Dalén P; Dahl ML; Bertilsson L Drug Metab Dispos; 1998 Nov; 26(11):1096-101. PubMed ID: 9806952 [TBL] [Abstract][Full Text] [Related]
32. Quinidine inhibits the 7-hydroxylation of chlorpromazine in extensive metabolisers of debrisoquine. Muralidharan G; Cooper JK; Hawes EM; Korchinski ED; Midha KK Eur J Clin Pharmacol; 1996; 50(1-2):121-8. PubMed ID: 8739822 [TBL] [Abstract][Full Text] [Related]
33. N-acetylation and debrisoquine type oxidation polymorphism in Caucasians--with reference to age and sex. Siegmund W; Hanke W; Zschiesche M; Franke G; Biebler KE; Wilke A Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):504-9. PubMed ID: 2086491 [TBL] [Abstract][Full Text] [Related]
34. [Assessment of biotransformation capacity following oral administration of various model substances as cocktail]. Henschel L; Hoffmann A Z Gastroenterol; 1991 Dec; 29(12):645-9. PubMed ID: 1771946 [TBL] [Abstract][Full Text] [Related]
35. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report]. Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Leszek J; Rudzik J; Grotthus B Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435 [TBL] [Abstract][Full Text] [Related]
36. Oxidative polymorphism of debrisoquine is not related to the risk of Alzheimer's disease. Benítez J; Barquero MS; Coria F; Molina JA; Jiménez-Jiménez FJ; Ladero JM J Neurol Sci; 1993 Jul; 117(1-2):8-11. PubMed ID: 8410072 [TBL] [Abstract][Full Text] [Related]
38. Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers. Graf T; Broly F; Hoffmann F; Probst M; Meyer UA; Howald H Eur J Clin Pharmacol; 1992; 43(4):399-403. PubMed ID: 1451720 [TBL] [Abstract][Full Text] [Related]
39. Polymorphic ochratoxin A hydroxylation in rat strains phenotyped as poor and extensive metabolizers of debrisoquine. Castegnaro M; Bartsch H; Bereziat JC; Arvela P; Michelon J; Broussolle L Xenobiotica; 1989 Feb; 19(2):225-30. PubMed ID: 2786290 [TBL] [Abstract][Full Text] [Related]
40. The influence of cimetidine on debrisoquine 4-hydroxylation in extensive metabolizers. Philip PA; James CA; Rogers HJ Eur J Clin Pharmacol; 1989; 36(3):319-21. PubMed ID: 2744073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]